1. Home
  2. INKT vs ANEB Comparison

INKT vs ANEB Comparison

Compare INKT & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INKT
  • ANEB
  • Stock Information
  • Founded
  • INKT 2017
  • ANEB 2020
  • Country
  • INKT United States
  • ANEB United States
  • Employees
  • INKT N/A
  • ANEB N/A
  • Industry
  • INKT Medicinal Chemicals and Botanical Products
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • INKT Health Care
  • ANEB Health Care
  • Exchange
  • INKT Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • INKT 43.0M
  • ANEB 36.7M
  • IPO Year
  • INKT 2021
  • ANEB 2021
  • Fundamental
  • Price
  • INKT $10.82
  • ANEB $1.47
  • Analyst Decision
  • INKT Strong Buy
  • ANEB Buy
  • Analyst Count
  • INKT 2
  • ANEB 1
  • Target Price
  • INKT $6.50
  • ANEB $8.00
  • AVG Volume (30 Days)
  • INKT 71.7K
  • ANEB 13.1K
  • Earning Date
  • INKT 03-20-2025
  • ANEB 02-21-2025
  • Dividend Yield
  • INKT N/A
  • ANEB N/A
  • EPS Growth
  • INKT N/A
  • ANEB N/A
  • EPS
  • INKT N/A
  • ANEB N/A
  • Revenue
  • INKT N/A
  • ANEB N/A
  • Revenue This Year
  • INKT N/A
  • ANEB N/A
  • Revenue Next Year
  • INKT N/A
  • ANEB N/A
  • P/E Ratio
  • INKT N/A
  • ANEB N/A
  • Revenue Growth
  • INKT N/A
  • ANEB N/A
  • 52 Week Low
  • INKT $4.56
  • ANEB $0.80
  • 52 Week High
  • INKT $19.00
  • ANEB $3.30
  • Technical
  • Relative Strength Index (RSI)
  • INKT 59.75
  • ANEB 44.55
  • Support Level
  • INKT $7.32
  • ANEB $1.45
  • Resistance Level
  • INKT $13.79
  • ANEB $1.72
  • Average True Range (ATR)
  • INKT 2.07
  • ANEB 0.14
  • MACD
  • INKT 0.28
  • ANEB -0.01
  • Stochastic Oscillator
  • INKT 71.94
  • ANEB 22.28

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Share on Social Networks: